Novartis has won approval in Japan for a new psoriasis drug, the first country to give the treatment a green light for commercialization.
WSJ.com: Europe Home, Wall Street Journal: World: Home Europe
Fri, 12/26/2014 - 5:57am
Novartis has won approval in Japan for a new psoriasis drug, the first country to give the treatment a green light for commercialization.